St. Vincent de Paul Charitable Pharmacy offers article regarding impact of a charitable pharmacy on their community and patients.
Related Posts
This study represents a rigorous, multi-state evaluation that highlights the impact of a charitable medication access program on hospital utilization for the medically under-served population.
Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.
The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023
Patients taking opioid dosages at or above 50 MME/day are twice as likely to overdose compared to those taking 20 MME/day, and the risk further increases as the MME/day increases.
Uninsured adults and those in worse health continue to report higher rates of not getting care due to costs
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…
How a ‘weighted lottery’ helped underserved patients get a scarce Covid drug
Want to learn more about Free and Charitable Clinics, Charitable Pharmacies and the medically underserved?
Just as banks have helped seniors bridge the digital divide and leverage online banking to better manage their money, healthcare organizations need to help older adults leverage digital technology to better manage their health.
How is a charitable pharmacy different from other types of pharmacies?
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
Patients taking opioid dosages at or above 50 MME/day are twice as likely to overdose compared to those taking 20 MME/day, and the risk further increases as the MME/day increases.
Significant improvement in glycemic control among participants demonstrates the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D